NASDAQ:MNTL Tema Neuroscience and Mental Health ETF (MNTL) Price, Holdings, & News $23.10 -0.36 (-1.51%) As of 09:31 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock About Tema Neuroscience and Mental Health ETF (NASDAQ:MNTL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MNTL alerts:Sign Up Key Stats Today's Range$23.15▼$23.1550-Day Range$21.63▼$23.4852-Week Range$19.86▼$27.66Volume26 shsAverage Volume408 shsMarket Capitalization$10.17 millionAssets Under Management$10.32 millionDividend Yield1.08%Net Expense Ratio0.75%Aggregate RatingModerate Buy ETF Overview The Tema Neuroscience and Mental Health ETF (MNTL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, concentrating on companies engaged in addressing disorders of the central nervous system and mental health worldwide. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. MNTL was launched on Jan 22, 2024 and is issued by Tema. Read More Tema Neuroscience and Mental Health ETF ExpensesTypeMNTLTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.99%0.57%0.56%0.54%0.53%Other Expenses0.00%0.58%0.56%0.52%0.56%Total Expense0.99%0.74%0.76%0.74%0.73%Fee Waiver-0.24%-0.76%-0.66%-0.50%-0.63%Net Expense0.75%0.60%0.63%0.63%0.60% Receive MNTL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tema Neuroscience and Mental Health ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address MNTL ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com MNTL ETF - Frequently Asked Questions How have MNTL shares performed this year? Tema Neuroscience and Mental Health ETF's stock was trading at $24.46 at the beginning of the year. Since then, MNTL shares have decreased by 5.5% and is now trading at $23.1050. How do I buy shares of Tema Neuroscience and Mental Health ETF? Shares of MNTL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssuerTema Global Fund NameTema Neuroscience and Mental Health ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:MNTL Inception Date1/22/2024 Fund ManagerDavid Song, Yuri Khodjamirian WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings95 Fund Statistics Assets Under Management$10.32 million Average Daily Volume$0.00 Discount/Premium0.01% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorTema Global Limited CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerOld Mission Options OptionableN/A Short Interest100 shs Miscellaneous Outstanding Shares440,000Beta0.99 Creation Unit10,000 Creation Fee$500.00 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Top 10 MNTL HoldingsVertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 10.43%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 8.10%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 6.49%Neurocrine Biosciences (NASDAQ:NBIX)Holding Weight: 5.02%Teva Pharmaceutical Industries (NYSE:TEVA)Holding Weight: 4.89%argenex (NASDAQ:ARGX)Holding Weight: 4.82%Eli Lilly and Company (NYSE:LLY)Holding Weight: 4.23%Crinetics Pharmaceuticals (NASDAQ:CRNX)Holding Weight: 3.82%Ionis Pharmaceuticals (NASDAQ:IONS)Holding Weight: 3.60%Stryker (NYSE:SYK)Holding Weight: 3.41%Full Holdings DetailsMNTL Sector ExposureMNTL Industry Exposure This page (NASDAQ:MNTL) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Neuroscience and Mental Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Neuroscience and Mental Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MNTL Stock Alerts